| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | -0.075 | 0.3 |
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | 0.029 | 0.3 |
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.036 | 0.3 |
| mRNA | KIN001-244 | GDSC1000 | pan-cancer | AAC | 0.031 | 0.3 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.3 |
| mRNA | Axitinib | FIMM | pan-cancer | AAC | -0.17 | 0.3 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | 0.029 | 0.3 |
| mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | 0.034 | 0.3 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.031 | 0.3 |